Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
As of today, Abbott(ABT) shares are valued at $110.45. The company's market cap stands at 194.3B, with a P/E ratio of 29.24 and a dividend yield of 2.2%.
During the trading session on 2026-02-07, Abbott(ABT) shares reached a daily high of $111.06 and a low of $108.95. At a current price of $110.45, the stock is +1.4% higher than the low and still -0.5% under the high.
Trading activity shows a volume of 9.92M, compared to an average daily volume of 14.68M.
The stock's 52-week range extends from a low of $105.27 to a high of $141.23.
The stock's 52-week range extends from a low of $105.27 to a high of $141.23.
ABT News
Abbott (ABT) announced new clinical data from two late-breaking presentations at AF Symposium in Boston that demonstrate the strong safety and efficacy of the c...
In late January 2026, Abbott Laboratories reported revenue and profit guidance below Wall Street expectations, highlighted ongoing weakness in its pediatric nut...
Abbott Laboratories (NYSE:ABT) CEO Robert Ford bought company shares after the latest earnings release and investor reaction. The purchase followed Abbott's an...
Analyst ratings
71%
of 31 ratingsMore ABT News
Bearish flow noted in Abbott (ABT) with 38,311 puts trading, or 1.6x expected. Most active are Feb-26 125 puts and Feb-26 130 puts, with total volume in those s...
The stock is near its 52-week low. Shares of Abbott Laboratories (ABT +0.10%) recently plunged after the company announced its fourth-quarter results. Over the...
Barclays lowered the firm’s price target on Abbott (ABT) to $142 from $169 and keeps an Overweight rating on the shares. The firm cites its reduced estimates an...
Abbott Laboratories (ABT) is back in focus after its fourth quarter update, where weakness in the Nutrition segment pulled overall sales growth below Wall Stree...
Key Points These companies have a long history of dividend growth, spanning more than 50 years. Passive income is something that rewards investors in any mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.